Soliris 300Mg Vial Of 30Ml Solution For Infusion
30ml Solution For Infusion in VialMRP ₹500000.00
₹449600.00
10% OFF
Made by
ASTRAZENECA PHARMA INDIA LTD
Dosage
SOLUTION FOR INFUSION
Expiry
General Information
| Uses | Paroxysmal nocturnal haemoglobinuria: This rare blood condition can destroy red blood cells; Soliris helps reduce that destruction and lowers related anaemia and blood clot risk., Atypical haemolytic uraemic syndrome: This immune-mediated illness can injure the kidneys and other organs; Soliris helps control the overactive immune attack., Generalised myasthenia gravis: An immune attack on nerve-muscle communication can cause weakness; Soliris may improve muscle strength and everyday functioning in eligible patients. |
| Side effects | Headache: Head pain can occur during or after the infusion. Tell the infusion team promptly if it is severe or comes with fever or a stiff neck., Nausea: An unsettled stomach may follow treatment. Ask the healthcare team for help if vomiting prevents you from keeping fluids down., Upper respiratory infection: A sore throat, cough or blocked nose can occur while immune protection is altered. Report fever or worsening symptoms promptly., Infusion or allergic reaction: Rash, itching, dizziness or breathing difficulty during or after treatment can signal a reaction. Get emergency medical help for breathing difficulty or swelling of the face, lips or throat., Serious meningococcal infection: Fever, severe headache, neck stiffness, confusion or a rash can worsen quickly while C5 is blocked. Get emergency medical help immediately. |
| Salt Content | Eculizumab(10.0 Mg/Ml) |
Medicines
available
19k pincodes
Medical Description
Soliris solution for infusion is a specialist medicine used for paroxysmal nocturnal haemoglobinuria, atypical haemolytic uraemic syndrome and generalised myasthenia gravis. It contains eculizumab, a laboratory-made antibody that blocks C5, a protein in the immune defence system. This reduces an overactive immune attack that can destroy red blood cells, injure organs or disrupt communication between nerves and muscles. It is reserved for selected conditions confirmed by a specialist and is given into a vein as an intravenous infusion by trained healthcare staff in a hospital or clinic.
Uses
- Paroxysmal nocturnal haemoglobinuria: This rare blood condition can destroy red blood cells; Soliris helps reduce that destruction and lowers related anaemia and blood clot risk.
- Atypical haemolytic uraemic syndrome: This immune-mediated illness can injure the kidneys and other organs; Soliris helps control the overactive immune attack.
- Generalised myasthenia gravis: An immune attack on nerve-muscle communication can cause weakness; Soliris may improve muscle strength and everyday functioning in eligible patients.
Contraindications
Side effects
- Headache: Head pain can occur during or after the infusion. Tell the infusion team promptly if it is severe or comes with fever or a stiff neck.
- Nausea: An unsettled stomach may follow treatment. Ask the healthcare team for help if vomiting prevents you from keeping fluids down.
- Upper respiratory infection: A sore throat, cough or blocked nose can occur while immune protection is altered. Report fever or worsening symptoms promptly.
- Infusion or allergic reaction: Rash, itching, dizziness or breathing difficulty during or after treatment can signal a reaction. Get emergency medical help for breathing difficulty or swelling of the face, lips or throat.
- Serious meningococcal infection: Fever, severe headache, neck stiffness, confusion or a rash can worsen quickly while C5 is blocked. Get emergency medical help immediately.
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Directions for Use
Storage and disposal
Quick Tips
- Keep the meningococcal vaccination and preventive treatment plan arranged by your specialist up to date.
- Carry treatment information or an alert card when travelling or seeking medical care.
- Get emergency medical help for fever, severe headache, neck stiffness, confusion or a rash.
- Attend blood tests and specialist appointments, and do not stop treatment without advice.
Dosage
Overdose
Missed a Dose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
Frequently Asked Questions (FAQs)
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:SOLIRIS
Manufacturer Name:ASTRAZENECA PHARMA INDIA LTD
Address:Alexion Pharmaceuticals, Inc. Boston, MA 02210 USA U.S. License No. 1743
Country of Origin:Usa
Vendor Details
Fulfillment Information: Soliris 10 MG/ML Solution For Infusion (30) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
